
Lilly's weight-loss pill meets main goal in late-stage sleep apnea study
来源:Reuters发布于 2026-11-09
Eli Lilly said on Monday its oral weight-loss drug Foundayo significantly reduced breathing interruptions during sleep in obese adults with moderate-to-severe obstructive sleep apnea, meeting the...
相关标的:LLY
本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。